125 related articles for article (PubMed ID: 21127468)
21. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.
Watterberg KL; Demers LM; Scott SM; Murphy S
Pediatrics; 1996 Feb; 97(2):210-5. PubMed ID: 8584379
[TBL] [Abstract][Full Text] [Related]
22. Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates.
Mittendorf R; Covert R; Montag AG; elMasri W; Muraskas J; Lee KS; Pryde PG
J Perinat Med; 2005; 33(5):428-34. PubMed ID: 16238538
[TBL] [Abstract][Full Text] [Related]
23. Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia.
Ogihara T; Hirano K; Morinobu T; Kim HS; Ogawa S; Hiroi M; Oue S; Ban R; Hira S; Hasegawa M; Yamaoka S; Yasui M
Pediatr Res; 2006 Nov; 60(5):613-8. PubMed ID: 16988187
[TBL] [Abstract][Full Text] [Related]
24. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia.
Kim BI; Lee HE; Choi CW; Jo HS; Choi EH; Koh YY; Choi JH
J Perinat Med; 2004; 32(3):282-7. PubMed ID: 15188806
[TBL] [Abstract][Full Text] [Related]
25. Clara cell secretory protein in tracheobronchial aspirates and umbilical cord serum of extremely premature infants with systemic inflammation.
Thomas W; Seidenspinner S; Kawczyńska-Leda N; Chmielnicka-Kopaczyk M; Marx A; Wirbelauer J; Szymankiewicz M; Speer CP
Neonatology; 2010; 97(3):228-34. PubMed ID: 19887851
[TBL] [Abstract][Full Text] [Related]
26. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants.
Janér J; Andersson S; Kajantie E; Lassus P
Pediatrics; 2009 Apr; 123(4):1142-6. PubMed ID: 19336373
[TBL] [Abstract][Full Text] [Related]
27. Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants.
Kaneko M; Sato M; Ogasawara K; Imamura T; Hashimoto K; Momoi N; Hosoya M
J Neonatal Perinatal Med; 2017; 10(2):147-155. PubMed ID: 28409755
[TBL] [Abstract][Full Text] [Related]
28. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
29. Chorioamnionitis and bronchopulmonary dysplasia in evolution.
Lands LC
Paediatr Respir Rev; 2014 Mar; 15(1):47-8. PubMed ID: 24210583
[No Abstract] [Full Text] [Related]
30. Dysplasia: a review.
Bokodi G; Treszl A; Kovács L; Tulassay T; Vásárhelyi B
Pediatr Pulmonol; 2007 Oct; 42(10):952-61. PubMed ID: 17726703
[TBL] [Abstract][Full Text] [Related]
31. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate.
Bose CL; Dammann CE; Laughon MM
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F455-61. PubMed ID: 18676410
[TBL] [Abstract][Full Text] [Related]
32. Histological chorioamnionitis and bronchopulmonary dysplasia: a retrospective cohort study.
Plakkal N; Soraisham AS; Trevenen C; Freiheit EA; Sauve R
J Perinatol; 2013 Jun; 33(6):441-5. PubMed ID: 23238570
[TBL] [Abstract][Full Text] [Related]
33. Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants.
Natarajan G; Glibetic M; Thomas RL; Aranda JV
Am J Perinatol; 2008 Sep; 25(8):491-7. PubMed ID: 18726836
[TBL] [Abstract][Full Text] [Related]
34. Reduced mortality and increased BPD with histological chorioamnionitis and leukocytosis in very-low-birth-weight infants.
Paul DA; Zook K; Mackley A; Locke RG
J Perinatol; 2010 Jan; 30(1):58-62. PubMed ID: 19710675
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.
Joseph L; Nir A; Hammerman C; Goldberg S; Ben Shalom E; Picard E
Am J Perinatol; 2010 May; 27(5):381-6. PubMed ID: 20013606
[TBL] [Abstract][Full Text] [Related]
36. That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against.
Lacaze-Masmonteil T
Paediatr Respir Rev; 2014 Mar; 15(1):53-5. PubMed ID: 24120077
[TBL] [Abstract][Full Text] [Related]
37. Early hypoadrenalism in premature infants at risk for bronchopulmonary dysplasia or death.
Nykänen P; Anttila E; Heinonen K; Hallman M; Voutilainen R
Acta Paediatr; 2007 Nov; 96(11):1600-5. PubMed ID: 17888053
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary inflammation and bronchopulmonary dysplasia.
Speer CP
J Perinatol; 2006 May; 26 Suppl 1():S57-62; discussion S63-4. PubMed ID: 16625227
[TBL] [Abstract][Full Text] [Related]
39. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.
Wang LY; Luo HJ; Hsieh WS; Hsu CH; Hsu HC; Chen PS; Chiu NC; Lee WT; Jeng SF
Pediatr Pulmonol; 2010 Feb; 45(2):165-73. PubMed ID: 20054861
[TBL] [Abstract][Full Text] [Related]
40. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia.
Speer CP
Neonatology; 2009; 95(4):353-61. PubMed ID: 19494557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
